# Uncommon Neuro-Ophthalmologic Findings in Pediatric Lyme Disease

**Authors:** Umme Habiba Fatima Syeda, Nika Bakshi, Eric Sherman

PMC · DOI: 10.7759/cureus.101250 · Cureus · 2026-01-10

## TL;DR

A young child with Lyme disease showed rare eye-related symptoms, highlighting the need for early diagnosis and treatment.

## Contribution

This case report highlights uncommon neuro-ophthalmologic manifestations of pediatric Lyme disease and emphasizes the importance of timely intervention.

## Key findings

- A four-year-old patient with Lyme disease exhibited bilateral optic nerve edema and abducens nerve palsy.
- Cerebrospinal fluid analysis confirmed Lyme neuroborreliosis with elevated intracranial pressure.
- Timely treatment led to clinical resolution of ocular and neurological symptoms.

## Abstract

Lyme disease (LD) is the most prevalent tick-borne illness in the United States and Europe, caused by a spirochete transmitted through the bite of an infected Ixodes tick. In this report, we present a case of disseminated Lyme disease in a four-year-old female who presented with constitutional symptoms and a recurrent, migratory erythema migrans-like rash for one month. The subsequent onset of eye deviation and vision complaints prompted referral, which revealed bilateral optic nerve edema and a left abducens nerve (CN VI) palsy. Cerebrospinal fluid analysis demonstrated an elevated Lyme antibody index, pleocytosis, and an elevated intracranial pressure of 40 cm H₂O. These findings are consistent with Lyme neuroborreliosis based on European Federation of Neurological Societies (EFNS) guidelines. The patient was treated with prednisolone eye drops, ceftriaxone, acetazolamide for intracranial hypertension, and doxycycline. Follow-up examination demonstrated clinical resolution of CN VI palsy and papilledema. This case highlights the importance of maintaining a high index of suspicion for Lyme disease in pediatric patients with neurologic or ocular symptoms following systemic or dermatologic findings suggestive of early Lyme disease. The rapid improvement of uncommon ocular manifestations further illustrates the potential role of timely inpatient evaluation and therapy.

## Linked entities

- **Chemicals:** doxycycline (PubChem CID 54671203), ceftriaxone (PubChem CID 5479530), prednisolone (PubChem CID 5755), acetazolamide (PubChem CID 1986)
- **Diseases:** Lyme disease (MONDO:0019632)

## Full-text entities

- **Diseases:** optic nerve edema (MESH:D000080344), papilledema (MESH:D010211), LD (MESH:D008193), intracranial hypertension (MESH:D019586), eye deviation (MESH:D010262), Lyme neuroborreliosis (MESH:D020852), CN VI palsy (MESH:D020434), pleocytosis (MESH:D007964), tick-borne illness (MESH:D017282), rash (MESH:D005076), erythema migrans (MESH:D005929)
- **Chemicals:** H2O. (MESH:D014867), doxycycline (MESH:D004318), acetazolamide (MESH:D000086), ceftriaxone (MESH:D002443), prednisolone (MESH:D011239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Ixodes (genus) [taxon 6944]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12885506/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12885506/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12885506/full.md

---
Source: https://tomesphere.com/paper/PMC12885506